Stroke and dementia are among the leading causes of death and disability in England. Research suggests that COVID-19 may increase the risk of both conditions. However, there is limited understanding of how COVID-19 interacts with vascular risk factors and medications… Read more

Existing evidence shows that most people would prefer to avoid admissions to hospital in the final months of life and to die at home. People who live in deprived areas are more likely to have more emergency hospital admissions in… Read more

Type 2 diabetes is one of the most common chronic diseases in the UK. With ~3.9 million people with diabetes in the UK, as of 2019, the number is increasing. Type 2 diabetes is when an individual is unable to… Read more

Artificial intelligence (AI) refers to computer systems that aim to perform tasks typically requiring human intelligence, such as problem-solving and decision-making. AI is a rapidly growing area of technology and innovation, sparking excitement about its potential for improving healthcare outcomes. Read more

Pulmonary arterial hypertension (PAH) is a serious condition that often affects people born with heart defects (congenital heart disease, CHD), even after surgery to repair their heart problem. This condition can make it hard for patients to breathe and do… Read more

UPDATE: This research project is currently paused pending a review. Further updates will be provided in due course. Who gets ill, when, and with which diseases and outcomes, are key questions for individuals, clinicians and healthcare systems. The COVID-19 pandemic… Read more

Healthcare planners need important epidemiological metrics for vascular diseases like heart attack and stroke. For example, they need to know how often people have diseases of different types (‘incidence’), how severe these diseases are (‘case fatality’), and how many people… Read more

This research project is awarded through a funding call by Health Data Research UK and the Alan Turing Institute as part of the wider Data and Connectivity National Core Study. Further details on this project are available here. Read more

This research project is awarded through a funding call by Health Data Research UK and the Alan Turing Institute as part of the wider Data and Connectivity National Core Study. Further details on this project are available here. Read more

Sight is the sense that is the most valued by the general public. The impact of the COVID-19 pandemic on sight loss and how the NHS manages eye disease remains under-researched. Some reports suggest that COVID-19 infection and/or vaccination may… Read more

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new virus responsible for the COVID-19 pandemic, which has caused many deaths worldwide. We are worried that some long-term (“chronic”) diseases, such as heart disease and diabetes, can worsen COVID-19… Read more

We know individuals with underlying health conditions have greater risk of developing severe COVID-19 and ending up with poorer outcomes. That is why governments and public health services have been providing dedicated and prioritised protections for these more clinically vulnerable… Read more

Since the first case of COVID-19 in the UK in January 2020, there have been nearly 4 million cases reported. Whilst most people have recovered with only mild to moderate symptoms, others have more severe symptoms requiring admission to hospital. Read more

Cardiovascular disease (CVD), comprising mostly heart attacks and strokes, is one of the UK’s leading causes of death and disability. It is far better and cheaper to prevent CVD than to treat patients after they get sick. Read more

Coronavirus (COVID-19) directly impacts individuals who become infected with the virus. It can also influence people’s healthcare decisions (such as deciding not to attend medical appointments for fear of infection). In addition, hospitals have sometimes had to prioritise treatment of… Read more